Drug interactions for the following drug(s)

Interactions between your selected drugs

diphenhydramine<>polyethylene glycol 3350

Applies to: Benadryl 2.5 MG/ML Oral Solution <> Miralax 17 GM per 4 OZ Powder for Oral Solution

The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Diphenhydramine.

The risk or severity of QTc prolongation can be increased when Famotidine is combined with Diphenhydramine.

The excretion of Famotidine can be decreased when combined with Pantoprazole.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 1049908, name = diphenhydramine hydrochloride 2.5 MG/ML Oral Solution [Benadryl], tty = SBD). Drug2 (rxcui = 876195, name = polyethylene glycol 3350 17000 MG Powder for Oral Solution [Miralax], tty = SBD). Drug1 is resolved to diphenhydramine, Drug2 is resolved to polyethylene glycol 3350 and interaction asserted in DrugBank between Diphenhydramine and Polyethylene glycol.

Drug1 (rxcui = 1049908, name = diphenhydramine hydrochloride 2.5 MG/ML Oral Solution [Benadryl], tty = SBD). Drug2 (rxcui = 310273, name = famotidine 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to diphenhydramine, Drug2 is resolved to famotidine and interaction asserted in DrugBank between Diphenhydramine and Famotidine.

Drug1 (rxcui = 310273, name = famotidine 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to famotidine, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Famotidine and Pantoprazole.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.